Zymeworks Inc (ZYME)
14.14
+0.56
(+4.12%)
USD |
NASDAQ |
Dec 20, 16:00
14.11
-0.03
(-0.21%)
After-Hours: 20:00
Zymeworks Profit Margin (Quarterly): -186.6% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc | 25.22% |
| Ligand Pharmaceuticals Inc | -13.84% |
| Cellectar Biosciences Inc | -- |
| Revance Therapeutics Inc | -63.65% |
| CNS Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -27.06% |
| Return on Assets | -21.10% |
| Return on Invested Capital | -27.06% |
| Operating Margin (Quarterly) | -214.1% |
| Return on Net Operating Assets | -112.0% |